The K-Map Study: Understanding Keratoconus Prevalence

This observational study, called the K-Map Study, is looking at how common keratoconus (KC) is in children and young adults around the world. Keratoconus is an eye condition that can cause blurry vision due to changes in the front clear part of your eye (cornea). Researchers believe it might be more common than previously thought. To find out, they will use a special camera called a Rotating Scheimpflug camera (Pentacam HR) to take pictures of the eyes of children and adolescents aged 6 to 23. You can join if you are in this age range and don't have any other eye conditions. The study aims to enroll 20,000 participants globally to get a clearer picture of KC prevalence.

Study design
This is an observational study with a planned enrollment of 20,000 participants. It is not a treatment study but aims to gather information about keratoconus.
What's involved
You will have one visit to the Ophthalmology Department, which will take about 15 minutes. This visit includes a questionnaire and the eye test using the Pentacam HR.
Compensation
Not stated in the trial record.
Follow-up
Your eye condition will be measured at 15 minutes during your single visit. No further follow-up is specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03115710

The K-Map Study, Global Prevalence of KC

Recruiting
Not specifiedAges 6–23Observational
University Hospital, Geneva
~20,000 participants
Updated 2025-08-11 on ClinicalTrials.gov
What's tested:Rotating Scheimpflug camera (Pentacam HR)

At a glance

Recruiting sites
10 of 12 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Prevalence of keratoconus
Measured over 15 minutes
Keratoconus
12 sites across 12 states
California1
China1
Croatia1
Egypt1
Germany1
Iran1
Jordan1
Mexico1
  • Farhad Hafezi · STUDY_DIRECTOR · ELZA Institute

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Male or female, 6-23 years of age.
Subjects seen for a non-ophthalmic appointment
Provide signed and dated patient consent form (signed by parents / legal guardians).
Willing to comply with all study procedures and be available for the duration of the study

Exclusion

Patients with a preexisting ocular disease / condition
Pregnancy or breastfeeding
  • Prevalence of keratoconus15 minutes

    Number of keratoconus cases detected